Financials

  • Market Capitalization 2.2 B
  • Employee 452
  • Founded 1999
  • CEO Paul Stoffels | Paul Stoffels
  • Website www.lakefrontbio.com
  • Headquarter Belgium
  • FIGI BBG000BJQY75
  • Industry N/A
Total revenue
Net income
Total debt
Free cash flow
Cash & equivalents

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
1810
CSQR
Csquare, Inc.
14.50 USD-4.54%-12.86%-11.31%-30.62%2.42 B USD
1827
USAR
USA Rare Earth Inc
6.27 USD-8.73%-18.15%-35.69%-99.49%2.36 B USD
1877
BULL
Webull Corporation - Class A
4.15 USD-9.19%-18.63%-30.37%-99.29%2.18 B USD
1882
ACCV
Accelevation Holdings Corp. Class A Ordinary Shares
9.58 USD-13.62%-23.67%-24.98%-45.41%2.16 B USD

Frequently asked questions about Lakefront Biotherapeutics American Depositary Shares

What is the Lakefront Biotherapeutics American Depositary Shares stock price today?

The current price of Lakefront Biotherapeutics American Depositary Shares (LKFT) is 33.31. Over the past 24 hours, the stock has changed by -0.24%. Follow the LKFT chart for real-time price dynamics.

What is the stock ticker of Lakefront Biotherapeutics American Depositary Shares?

Lakefront Biotherapeutics American Depositary Shares trades under the ticker LKFT. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is Lakefront Biotherapeutics American Depositary Shares stock going up?

LKFT has changed by -3.45% over the last week, +8.79% over the last month, and +13.49% over the last year. Review the chart to see whether the current move is part of a broader trend.

What is the market capitalization of Lakefront Biotherapeutics American Depositary Shares?

Lakefront Biotherapeutics American Depositary Shares currently has a market capitalization of 2.2 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

What was Lakefront Biotherapeutics American Depositary Shares revenue for the last quarter?

Lakefront Biotherapeutics American Depositary Shares reported quarterly revenue of 54.43 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

How many employees does Lakefront Biotherapeutics American Depositary Shares have?

As of the latest available data, Lakefront Biotherapeutics American Depositary Shares has 452 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy Lakefront Biotherapeutics American Depositary Shares stock?

You can buy Lakefront Biotherapeutics American Depositary Shares (LKFT) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in Lakefront Biotherapeutics American Depositary Shares stock?

Investing in Lakefront Biotherapeutics American Depositary Shares requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the LKFT chart and related analysis on metatrader.com as part of your research.

Lakefront Biotherapeutics American Depositary Shares

Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis.